Alerje develops a food allergy management application that utilizes data from Oral Immunotherapy (OIT) studies to enhance treatment adherence and reduce allergic reactions. The platform empowers families to effectively monitor and manage food allergies, addressing the challenges faced by over 220 million individuals worldwide.
Funding
$2.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
LHFounders
Product
Problem
Over 220 million people worldwide suffer from food allergies, requiring constant vigilance and proactive management to avoid potentially life-threatening reactions. Effectively monitoring and managing these allergies presents significant challenges for both individuals and their families.
Solution
Alerje is developing a technology platform designed to improve the lives of food allergy families. The platform utilizes data from Oral Immunotherapy (OIT) studies to enhance treatment adherence and reduce allergic reactions. By leveraging technology, Alerje aims to deliver safe and effective solutions that empower individuals and families to take control of their food allergies.
Target Audience
The primary target audience includes individuals with food allergies, their families, and healthcare providers involved in allergy management.
Features
- Integration of data from Oral Immunotherapy (OIT) studies to improve treatment outcomes.
- Tools for monitoring and managing food allergies.
- Educational resources, including the "Smart Defenders" comic series, to help families navigate food allergy challenges.
- A National Science Foundation (NSF) study focused on improving the OIT treatment experience and adherence.